Advertisement

European Journal of Dermatology

, Volume 28, Issue 5, pp 685–687 | Cite as

The DRAGON study: biologic DRug survivAl in PortuGuese psOriasis patieNts

  • Tiago TorresEmail author
  • Paulo Filipe
  • Artur Sousa Basto
  • José Carlos Fernandes
  • Ana Ferreira
  • Aristóteles Rosmaninho
  • Marta Pereira
  • Luíz Leite
  • Jorge Luís Navarro
  • Ricardo Coelho
  • Paulo Ferreira
  • Manuela Selores
Article
  • 2 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Puig L, López A, Vilarrasa E, García I. Efficacy of biologics in the treatment of moderate–to–severe plaque psoriasis: a systematic review and meta–analysis of randomized controlled trials with different time points. J Eur Acad Dermatol Venereol 2014; 28: 1633–53.CrossRefGoogle Scholar
  2. 2.
    de Groot M, Appelman M, Spuls PI, de Rie MA, Bos JD. Initial experience with routine administration of etanercept in psoriasis. Br J Dermatol 2006; 155: 808–14.CrossRefGoogle Scholar
  3. 3.
    Gniadecki R, Bang B, Bryld LE, Iversen L, Lasthein S, Skov L. Comparison of long–term drug survival and safety of biologic agents in patients with psoriasis vulgaris. Br J Dermatol 2015; 172: 244–52.CrossRefGoogle Scholar
  4. 4.
    Warren RB, Smith CH, Yiu ZZN, et al. Differential drug survival of biologic therapies for the treatment of psoriasis: a prospective observational cohort study from the British Association of Derma tologists Biologic Interventions Register (BADBIR). J Invest Dermatol 2015; 135: 2632–40.CrossRefGoogle Scholar
  5. 5.
    Menter A, Papp KA, Gooderham M, et al. Drug survival of biologic therapy in a large, disease–based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). J Eur Acad Dermatol Venereol 2016; 30: 1148–58.CrossRefGoogle Scholar
  6. 6.
    Zweegers J, Groenewoud JMM, van den Reek JMPA, et al. Comparison of the 1–and 5–year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry. Br J Dermatol 2017; 176: 1001–9.CrossRefGoogle Scholar
  7. 7.
    Egeberg A, Ottosen MB, Gniadecki R, et al. Safety, efficacy and drug survival of biologics and biosimilars for moderate–to–severe plaque psoriasis. Br J Dermatol 2018; 178: 509–19.CrossRefGoogle Scholar
  8. 8.
    Kalb RE, Fiorentino DF, Lebwohl MG, et al. Risk of serious infection with biologic and systemic treatment of psoriasis. JAMA Dermatol 2015; 151: 961–9.CrossRefGoogle Scholar
  9. 9.
    Strober BE, Bissonnette R, Fiorentino D, et al. Comparative effectiveness of biologic agents for the treatment of psoriasis in a real–world setting: results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR]). J Am Acad Dermatol 2016; 74: 851–61.e4.CrossRefGoogle Scholar
  10. 10.
    Zhang M, Brenneman S, Carter C, et al. Patient–reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis. Patient Prefer Adherence 2015; 16: 777–84.CrossRefGoogle Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Tiago Torres
    • 1
    • 2
    Email author
  • Paulo Filipe
    • 3
    • 4
  • Artur Sousa Basto
    • 5
  • José Carlos Fernandes
    • 5
  • Ana Ferreira
    • 6
  • Aristóteles Rosmaninho
    • 7
  • Marta Pereira
    • 8
  • Luíz Leite
    • 9
  • Jorge Luís Navarro
    • 5
  • Ricardo Coelho
    • 10
  • Paulo Ferreira
    • 11
  • Manuela Selores
    • 1
    • 2
  1. 1.Serviço de DermatologiaCentro Hospitalar e Universitário do PortoLisboaPortugal
  2. 2.Instituto de Ciências Biomédicas Abel SalazarUniversidade do PortoLisboaPortugal
  3. 3.Serviço de DermatologiaCentro Hospitalar Lisboa NorteLisboaPortugal
  4. 4.Unidade de Investigação em Dermatologia do Instituto de Medicina MolecularUniversidade de LisboaLisboaPortugal
  5. 5.Clínica PrivadaLisboaPortugal
  6. 6.Serviço de DermatologiaCentro Hospitalar de Lisboa CentralLisboaPortugal
  7. 7.Serviço de DermatologiaUnidade Local de Saúde do Alto MinhoLisboaPortugal
  8. 8.Serviço de DermatologiaUnidade Local de Saúde de MatosinhosMatosinhosPortugal
  9. 9.Clínica Laser de BelémLisboaPortugal
  10. 10.Serviço de Dermatologia, Hospital Garcia de OrtaAlmadaPortugal
  11. 11.Hospital CUF – DescobertasLisboaPortugal

Personalised recommendations